Drug Insights

Strategically Search Atorvastatin on Synapse: A How-to Guide

1 February 2024
2 min read

Atorvastatin is a medication that inhibits the HMG-CoA reductase enzyme. Hanmi Pharmaceutical Co., Ltd approved it in January 2008. It is used to treat hyperlipidemias, which is a condition characterized by elevated cholesterol and triglycerides in the blood. Atorvastatin belongs to a class of drugs known as HMG-CoA reductase inhibitors, also known as statins. These medications work by preventing the enzyme responsible for producing cholesterol in the liver from functioning. By lowering cholesterol levels in the blood, atorvastatin helps reduce the risk of heart disease and stroke. The medication is generally well-tolerated, but some patients may experience side effects such as muscle pain, weakness, and liver dysfunction. Click on the image below to begin the exploration journey of Atorvastatin through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Sciwind Biosciences Announces Promising Initial Clinical Results for Oral, Sustained-Release GLP-1 Mimetic Ecnoglutide, XW004
Latest Hotspot
4 min read
Sciwind Biosciences Announces Promising Initial Clinical Results for Oral, Sustained-Release GLP-1 Mimetic Ecnoglutide, XW004
1 February 2024
Sciwind Biosciences Reports Encouraging Outcomes from Initial Clinical Study of XW004, Its Oral Version of Sustained-Release GLP-1 Mimetic Ecnoglutide.
Read →
User-friendly Guide to Find Trazodone on Synapse
Drug Insights
2 min read
User-friendly Guide to Find Trazodone on Synapse
1 February 2024
Trazodone, a selective inhibitor of serotonin reuptake transporter 5, has been a key treatment for depression since its approval in Dec 1981 by Angelini Pharma.
Read →
Harnessing Synapse for Acetaminophen Information: Strategies and Tips
Drug Insights
2 min read
Harnessing Synapse for Acetaminophen Information: Strategies and Tips
1 February 2024
Acetaminophen, a small molecule COX enzyme inhibitor drug approved in January 1966, is widely used for pain relief and fever reduction.
Read →
Locus Biosciences Secures $23.9M BARDA Investment for Phase 2 of Groundbreaking CRISPR Phage Treatment
Latest Hotspot
3 min read
Locus Biosciences Secures $23.9M BARDA Investment for Phase 2 of Groundbreaking CRISPR Phage Treatment
1 February 2024
Locus Biosciences has disclosed receiving a $23.9 million investment from BARDA, intended to back the inaugural Phase 2 study of its groundbreaking CRISPR-crafted phage treatment.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.